G
Gabriella Tamasi
Researcher at University of Siena
Publications - 95
Citations - 1721
Gabriella Tamasi is an academic researcher from University of Siena. The author has contributed to research in topics: Ligand & Chemistry. The author has an hindex of 21, co-authored 88 publications receiving 1373 citations. Previous affiliations of Gabriella Tamasi include University of Southampton & University of Florence.
Papers
More filters
Journal ArticleDOI
Heavy metals in drinking waters from Mount Amiata (Tuscany, Italy). Possible risks from arsenic for public health in the Province of Siena
Gabriella Tamasi,Renzo Cini +1 more
TL;DR: A general 'metal index' for drinking water, which takes into account possible additive effects of N heavy metals on the human health that helps to quickly evaluate the overall quality of drinking waters, is introduced in this paper as MI=?(i=1,N)[C(i)/(MAC)(i)].
Journal ArticleDOI
Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)–isoxicam, –meloxicam and –cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)–piroxicam complex
TL;DR: Cytotoxic tests recently performed at National Cancer Institute, NCI (USA), on [Cu(HPIR)(2)(DMF)(2)], 1, (H(2)PIR=piroxicam) a widely used non-steroidal anti-inflammatory drug, NSAID, showed growth inhibition factor GI(50) values as low as 20microM against several cancer lines, with an average value 54.4microM.
Journal ArticleDOI
Protective effect of quercetin and rutin encapsulated liposomes on induced oxidative stress.
Claudia Bonechi,Claudia Bonechi,Alessandro Donati,Alessandro Donati,Gabriella Tamasi,Gemma Leone,Marco Consumi,Claudio Rossi,Stefania Lamponi,Agnese Magnani +9 more
TL;DR: All data suggest that the tested liposomes are stable and able to include quercetin and rutin, and Liposomes stability together with their good in vitro cytocompatibility makes these systems suitable candidates as drug delivery systems.
Journal ArticleDOI
Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
TL;DR: The release studies performed by monitoring both the absorbance values at 362 nm (sensitive to metal-bound HPIR(-)) and the content of Cu via AAS, showed an excellent agreement with the Cu(HPIR)(2) or Cu(2) stoichiometry, depending on the delivery medium.
Journal ArticleDOI
fac-{Ru(CO)(3)}(2+) selectively targets the histidine residues of the beta-amyloid peptide 1-28. Implications for new Alzheimer's disease treatments based on ruthenium complexes.
Daniela Valensin,Paolo Anzini,Elena Gaggelli,Nicola Gaggelli,Gabriella Tamasi,Renzo Cini,Chiara Gabbiani,Elena Michelucci,Luigi Messori,Henryk Kozlowski,Gianni Valensin +10 more
TL;DR: The reaction of the ruthenium(II) complex with human beta-amyloid peptide 1-28 (Abeta(28)) and the resulting {Ru(CO)(3)}(2+) peptide adduct was investigated by a variety of biophysical methods, revealing the nature of peptide-bound metallic fragments.